MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update
07 nov. 2024 07h00 HE
|
MoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term marketable...